The ADAMTS family of metalloproteinases

Extracellular Matrix: Pathobiology and Signaling

Volumn , Issue , 2012, Pages 315-342

  Nagase, Hideaki ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84923243574     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (149)

1. Abbaszade, I., Liu, R. Q., Yang, F., et al. (1999). Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family. J Biol Chem 274, 23443-23450.
2. Akiyama, M., Takeda, S., Kokame, K., Takagi, J., and Miyata, T. (2009). Crystal structures of the noncatalytic domains of ADAMTS13 reveal multiple discontinuous exosites for von Willebrand factor. Proc Natl Acad Sci U S A 106, 19274-19279.
3. Apte, S. S. (2004). A disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motifs: the ADAMTS family. Int J Biochem Cell Biol 36, 981-985.
4. Apte, S. S. (2009). A disintegrin-like and metalloprotease (reprolysin-type) with thrombospondin type 1 motif (ADAMTS) superfamily: functions and mechanisms. J Biol Chem 284, 31493-31497.
5. Bagavandoss, P., and Wilks, J. W. (1990). Specific inhibition of endothelial cell proliferation by thrombospondin. Biochem Biophys Res Commun 170, 867-872.
6. Bau, B., Gebhard, P. M., Haag, J., Knorr, T., Bartnik, E., and Aigner, T. (2002). Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro. Arthritis Rheum 46, 2648-2657.
7. Baumann, U. (1994). Crystal structure of the 50 kDa metallo protease from Serratia marcescens. J Mol Biol 242, 244-251.
8. Becker, J. W., Marcy, A. I., Rokosz, L. L., et al. (1995). Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme. Protein Sci 4, 1966-1976.
9. Black, R. A., Rauch, C. T., Kozlosky, C. J., et al. (1997). A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385, 729-733.
10. Blelloch, R., and Kimble, J. (1999). Control of organ shape by a secreted metalloprotease in the nematode Caenorhabditis elegans. Nature 399, 586-590.
11. Blobel, C. P. (2005). ADAMs: key components in EGFR signalling and development. Nat Rev Mol Cell Biol 6, 32-43.
12. Bode, W., Gomis-Rüth, F. X., and Stöckler, W. (1993). Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXXHXXGXXH and Met-turn) and topologies and should be grouped into a common family, the "metzincins." FEBS Lett 331, 134-140.
13. Bode, W., Reinemer, P., Huber, R., Kleine, T., Schnierer, S., and Tschesche, H. (1994). The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity. EMBO J 13, 1263-1269.
14. Bolz, H., Ramirez, A., von Brederlow, B., and Kubisch, C. (2001). Characterization of ADAMTS14, a novel member of the ADAMTS metalloproteinase family. Biochim Biophys Acta 1522, 221-225.
15. Bongrazio, M., Baumann, C., Zakrzewicz, A., Pries, A. R., and Gaehtgens, P. (2000). Evidence for modulation of genes involved in vascular adaptation by prolonged exposure of endothelial cells to shear stress. Cardiovasc Res 47, 384-393.
16. Brew, K., and Nagase, H. (2010). The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim Biophys Acta 1803, 55-71.
17. Brinckerhoff, C. E., and Matrisian, L. M. (2002). Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol 3, 207-214.
18. Capehart, A. A. (2010). Proteolytic cleavage of versican during limb joint development. Anat Rec 293, 208-214.
19. Colige, A., Li, S. W., Sieron, A. L., Nusgens, B. V., Prockop, D. J., and Lapiere, C. M. (1997). cDNA cloning and expression of bovine procollagen I N-proteinase: a new member of the superfamily of zinc-metalloproteinases with binding sites for cells and other matrix components. Proc Natl Acad Sci U S A 94, 2374-2379.
20. Colige, A., Sieron, A. L., Li, S. W., et al. (1999). Human Ehlers-Danlos syndrome type VII C and bovine dermatosparaxis are caused by mutations in the procollagen I N-proteinase gene. Am J Hum Genet 65, 308-317.
21. Collins-Racie, L. A., Flannery, C. R., Zeng, W., et al. (2004). ADAMTS-8 exhibits aggrecanase activity and is expressed in human articular cartilage. Matrix Biol 23, 219-230.
22. Demircan, K., Hirohata, S., Nishida, K., et al. (2005). ADAMTS-9 is synergistically induced by interleukin-1 B and tumor necrosis factor A in OUMS-27 chondrosarcoma cells and in human chondrocytes. Arthritis Rheum 52, 1451-1460.
23. Dubail, J., Kesteloot, F., Deroanne, C., et al. (2010). ADAMTS-2 functions as anti-angiogenic and anti-tumoral molecule independently of its catalytic activity. Cell Mol Life Sci 67, 4213-4232.
24. Dudas, M., Li, W. Y., Kim, J., Yang, A., and Kaartinen, V. (2007). Palatal fusion - where do the midline cells go? A review on cleft palate, a major human birth defect. Acta Histochem 109, 1-14.
25. Dupuis, L. E., McCulloch, D. R., McGarity, J. D., et al. (2011). Altered versican cleavage in ADAMTS5 deficient mice; a novel etiology of myxomatous valve disease. Dev Biol 357, 152-164.
26. Durigova, M., Soucy, P., Fushimi, K., Nagase, H., Mort, J. S., and Roughley, P. J. (2008). Characterization of an ADAMTS-5-mediated cleavage site in aggrecan in OSM-stimulated bovine cartilage. Osteoarthritis Cartilage 16, 1245-1252.
27. Edwards, D. R., Handsley, M. M., and Pennington, C. J. (2008). The ADAM metalloproteinases. Mol Aspects Med 29, 258-289.
28. Enomoto, H., Nelson, C. M., Somerville, R. P., et al. (2010). Cooperation of two ADAMTS metalloproteases in closure of the mouse palate identifies a requirement for versican proteolysis in regulating palatal mesenchyme proliferation. Development 137, 4029-4038.
29. Fernandes, R. J., Hirohata, S., Engle, J. M., et al. (2001). Procollagen II amino propeptide processing by ADAMTS-3. Insights on dermatosparaxis. J Biol Chem 276, 31502-31509.
30. Fernando, T., Flibotte, S., Xiong, S., et al. (2011). C. elegans ADAMTS ADT-2 regulates body size by modulating TGFbeta signaling and cuticle collagen organization. Dev Biol 352, 92-103.
31. Flannery, C. R., Little, C. B., Hughes, C. E., and Caterson, B. (1999). Expression of ADAMTS homologues in articular cartilage. Biochem Biophys Res Commun 260, 318-322.
32. Fogal, V., Sugahara, K. N., Ruoslahti, E., and Christian, S. (2009). Cell surface nucleolin antagonist causes endothelial cell apoptosis and normalization of tumor vasculature. Angiogenesis 12, 91-100.
33. Fosang, A. J., Rogerson, F. M., East, C. J., and Stanton, H. (2008). ADAMTS-5: the story so far. Eur Cell Mater 15, 11-26.
34. Fujikawa, K., Suzuki, H., McMullen, B., and Chung, D. (2001). Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. Blood 98, 1662-1666.
35. Fushimi, K., Troeberg, L., Nakamura, H., Lim, N. H., and Nagase, H. (2008). Functional differences of the catalytic and non-catalytic domains in human ADAMTS-4 and ADAMTS-5 in aggrecanolytic activity. J Biol Chem 283, 6706-6716.
36. Gao, G., Plaas, A., Thompson, V. P., Jin, S., Zuo, F., and Sandy, J. D. (2004). ADAMTS4 (aggrecanase-1) activation on the cell surface involves C-terminal cleavage by glycosylphosphatidyl inositol-anchored membrane type 4-matrix metalloproteinase and binding of the activated proteinase to chondroitin sulfate and heparan sulfate on syndecan-1. J Biol Chem 279, 10042-10051.
37. Gao, W., Anderson, P. J., Majerus, E. M., Tuley, E. A., and Sadler, J. E. (2006). Exosite interactions contribute to tension-induced cleavage of von Willebrand factor by the antithrombotic ADAMTS13 metalloprotease. Proc Natl Acad Sci U S A 103, 19099-19104.
38. Gao, W., Anderson, P. J., and Sadler, J. E. (2008). Extensive contacts between ADAMTS13 exosites and von Willebrand factor domain A2 contribute to substrate specificity. Blood 112, 1713-1719.
39. Gendron, C., Kashiwagi, M., Hughes, C., Caterson, B., and Nagase, H. (2003). TIMP-3 inhibits aggrecanase-mediated glycosaminoglycan release from cartilage explants stimulated by catabolic factors. FEBS Lett 555, 431-436.
40. Gendron, C., Kashiwagi, M., Lim, N. H., et al. (2007). Proteolytic activities of human ADAMTS-5: comparative studies with ADAMTS-4. J Biol Chem 282, 18294-18306.
41. Gerhardt, S., Hassall, G., Hawtin, P., et al. (2007). Crystal structures of human ADAMTS-1 reveal a conserved catalytic domain and a disintegrin-like domain with a fold homologous to cysteine-rich domains. J Mol Biol 373, 891-902.
42. Gerritsen, H. E., Robles, R., Lammle, B., and Furlan, M. (2001). Partial amino acid sequence of purified von Willebrand factor-cleaving protease. Blood 98, 1654-1661.
43. Ghosh, P. (1999). The pathobiology of osteoarthritis and the rationale for the use of pentosan polysulfate for its treatment. Semin Arthritis Rheum 28, 211-267.
44. Glasson, S. S., Askew, R., Sheppard, B., et al. (2004). Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice. Arthritis Rheum 50, 2547-2558.
45. Glasson, S. S., Askew, R., Sheppard, B., et al. (2005). Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 434, 644-648.
46. Gomis-Ruth, F. X. (2003). Structural aspects of the metzincin clan of metalloendopeptidases. Mol Biotechnol 24, 157-202.
47. Gomis-Ruth, F. X., Kress, L. F., and Bode, W. (1993). First structure of a snake venom metalloproteinase: a prototype for matrix metalloproteinases/collagenases. EMBO J 12, 4151-4157.
48. Good, D. J., Polverini, P. J., Rastinejad, F., et al. (1990). A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci U S A 87, 6624-6628.
49. Gross, J., and Lapiere, C. M. (1962). Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Natl Acad Sci U S A 48, 1014-1022.
50. Guo, F., Lai, Y., Tian, Q., Lin, E. A., Kong, L., and Liu, C. (2010). Granulin-epithelin precursor binds directly to ADAMTS-7 and ADAMTS-12 and inhibits their degradation of cartilage oligomeric matrix protein. Arthritis Rheum 62, 2023-2036.
51. Gupta, V., Barzilla, J. E., Mendez, J. S., et al. (2009). Abundance and location of proteoglycans and hyaluronan within normal and myxomatous mitral valves. Cardiovasc Pathol 18, 191-197.
52. Hattori, N., Carrino, D. A., Lauer, M. E., et al. (2011). Pericellular versican regulates the fibroblast-myofibroblast transition: a role for ADAMTS5 protease-mediated proteolysis. J Biol Chem 286, 34298-34310.
53. Hulmes, D. J., Kadler, K. E., Mould, A. P., et al. (1989). Pleomorphism in type I collagen fibrils produced by persistence of the procollagen N-propeptide. J Mol Biol 210, 337-345.
54. Hurskainen, T. L., Hirohata, S., Seldin, M. F., and Apte, S. S. (1999). ADAM-TS5, ADAM-TS6, and ADAM-TS7, novel members of a new family of zinc metalloproteases. General features and genomic distribution of the ADAM-TS family. J Biol Chem 274, 25555-25563.
55. Huxley-Jones, J., Apte, S. S., Robertson, D. L., and Boot-Handford, R. P. (2005). The characterisation of six ADAMTS proteases in the basal chordate Ciona intestinalis provides new insights into the vertebrate ADAMTS family. Int J Biochem Cell Biol 37, 1838-1845.
56. Ihara, S., and Nishiwaki, K. (2008). Stage-specific activation of MIG-17/ADAMTS controls cell migration in Caenorhabditis elegans. FEBS J 275, 4296-4305.
57. Ilic, M. Z., Handley, C. J., Robinson, H. C., and Mok, M. T. (1992). Mechanism of catabolism of aggrecan by articular cartilage. Arch Biochem Biophys 294, 115-122.
58. Iruela-Arispe, M. L., Bornstein, P., and Sage, H. (1991). Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. Proc Natl Acad Sci U S A 88, 5026-5030.
59. Janes, P. W., Saha, N., Barton, W. A., et al. (2005). Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans. Cell 123, 291-304.
60. Jenni, R., Rojas, J., and Oechslin, E. (1999). Isolated noncompaction of the myocardium. N Engl J Med 340, 966-967.
61. Jonsson-Rylander, A. C., Nilsson, T., Fritsche-Danielson, R., et al. (2005). Role of ADAMTS-1 in atherosclerosis: remodeling of carotid artery, immunohistochemistry, and proteolysis of versican. Arterioscler Thromb Vasc Biol 25, 180-185.
62. Kashiwagi, M., Enghild, J. J., Gendron, C., et al. (2004). Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing. J Biol Chem 279, 10109-10119.
63. Kenagy, R. D., Min, S. K., Clowes, A. W., and Sandy, J. D. (2009). Cell death-associated ADAMTS4 and versican degradation in vascular tissue. J Histochem Cytochem 57, 889-897.
64. Kern, C. B., Twal, W. O., Mjaatvedt, C. H., et al. (2006). Proteolytic cleavage of versican during cardiac cushion morphogenesis. Dev Dyn 235, 2238-2247.
65. Kevorkian, L., Young, D. A., Darrah, C., et al. (2004). Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis Rheum 50, 131-141.
66. Koo, B. H., Coe, D. M., Dixon, L. J., et al. (2010). ADAMTS9 is a cell-autonomously acting, anti-angiogenic metalloprotease expressed by microvascular endothelial cells. Am J Pathol 176, 1494-1504.
67. Koo, B. H., Longpré, J. M., Somerville, R. P., Alexander, J. P., Leduc, R., and Apte, S. S. (2006). Cell-surface processing of pro-ADAMTS9 by furin. J Biol Chem 281, 12485-12494.
68. Koo, B. H., Longpré, J. M., Somerville, R. P., Alexander, J. P., Leduc, R., and Apte, S. S. (2007). Regulation of ADAMTS9 secretion and enzymatic activity by its propeptide. J Biol Chem 282, 16146-16154.
69. Krampert, M., Kuenzle, S., Thai, S. N., Lee, N., Iruela-Arispe, M. L., and Werner, S. (2005). ADAMTS1 proteinase is up-regulated in wounded skin and regulates migration of fibroblasts and endothelial cells. J Biol Chem 280, 23844-23852.
70. Kuno, K., Baba, C., Asaka, A., Matsushima, C., Matsushima, K., and Hosono, R. (2002). The Caenorhabditis elegans ADAMTS family gene adt-1 is necessary for morphogenesis of the male copulatory organs. J Biol Chem 277, 12228-12236.
71. Kuno, K., Kanada, N., Nakashima, E., Fujiki, F., Ichimura, F., and Matsushima, K. (1997). Molecular cloning of a gene encoding a new type of metalloproteinase-disintegrin family protein with thrombospondin motifs as an inflammation associated gene. J Biol Chem 272, 556-562.
72. Lark, M. W., Bayne, E. K., Flanagan, J., et al. (1997). Aggrecan degradation in human cartilage - evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints. J Clin Invest 100, 93-106.
73. Lee, N. V., Sato, M., Annis, D. S., et al. (2006). ADAMTS1 mediates the release of antiangiogenic polypeptides from TSP1 and 2. EMBO J 25, 5270-5283.
74. Levy, G. G., Nichols, W. C., Lian, E. C., et al. (2001). Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 413, 488-494.
75. Li, S. W., Arita, M., Fertala, A., et al. (2001). Transgenic mice with inactive alleles for procollagen N-proteinase (ADAMTS-2) develop fragile skin and male sterility. Biochem J 355, 271-278.
76. Li, Z., Nard, M. A., Li, Y. S., et al. (2009). C-terminal ADAMTS-18 fragment induces oxidative platelet fragmentation, dissolves platelet aggregates, and protects against carotid artery occusion and cerebral stroke. Blood 113, 6051-6060.
77. Liu, C. J., Kong, W., Ilalov, K., et al. (2006a). ADAMTS-7: a metalloproteinase that directly binds to and degrades cartilage oligomeric matrix protein. FASEB J 20, 988-990.
78. Liu, C. J., Kong, W., Xu, K., et al. (2006b). ADAMTS-12 associates with and degrades cartilage oligomeric matrix protein. J Biol Chem 281, 15800-15808.
79. Llamazares, M., Obaya, A. J., Moncada-Pazos, A., et al. (2007). The ADAMTS12 metalloproteinase exhibits anti-tumorigenic properties through modulation of the Ras-dependent ERK signalling pathway. J Cell Sci 120, 3544-3552.
80. Lo, P. H., Lung, H. L., Cheung, A. K., et al. (2010). Extracellular protease ADAMTS9 suppresses esophageal and nasopharyngeal carcinoma tumor formation by inhibiting angiogenesis. Cancer Res 70, 5567-5576.
81. Lohmander, L. S., Neame, P. J., and Sandy, J. D. (1993). The structure of aggrecan fragments in human synovial fluid. Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis. Arthritis Rheum 36, 1214-1222.
82. Longpré, J. M., and Leduc, R. (2004). Identification of prodomain determinants involved in ADAMTS-1 biosynthesis. J Biol Chem 279, 33237-33245.
83. Longpré, J. M., McCulloch, D. R., Koo, B. H., Alexander, J. P., Apte, S. S., and Leduc, R. (2009). Characterization of proADAMTS5 processing by proprotein convertases. Int J Biochem Cell Biol 41, 1116-1126.
84. Lotta, L. A., Garagiola, I., Palla, R., Cairo, A., and Peyvandi, F. (2010). ADAMTS13 mutations and polymorphisms in congenital thrombotic thrombocytopenic purpura. Hum Mutat 31, 11-19.
85. Loulakis, P., Shrikhande, A., Davis, G., and Maniglia, C. A. (1992). N-terminal sequence of proteoglycan fragments isolated from medium of interleukin-1-treated articular-cartilage cultures. Putative site(s) of enzymic cleavage. Biochem J 284, 589-593.
86. Lovejoy, B., Cleasby, A., Hassell, A. M., et al. (1994). Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor. Science 263, 375-377.
87. Luken, B. M., Turenhout, E. A., Kaijen, P. H., et al. (2006). Amino acid regions 572-579 and 657-666 of the spacer domain of ADAMTS13 provide a common antigenic core required for binding of antibodies in patients with acquired TTP. Thromb Haemost 96, 295-301.
88. Luque, A., Carpizo, D. R., and Iruela-Arispe, M. L. (2003). ADAMTS1/METH1 inhibits endothelial cell proliferation by direct binding and sequestration of VEGF165. J Biol Chem 278, 23656-23665.
89. Majerus, E. M., Anderson, P. J., and Sadler, J. E. (2005). Binding of ADAMTS13 to von Willebrand factor. J Biol Chem 280, 21773-21778.
90. McCulloch, D. R., Le Goff, C., Bhatt, S., Dixon, L. J., Sandy, J. D., and Apte, S. S. (2009). Adamts5, the gene encoding a proteoglycan-degrading metalloprotease, is expressed by specific cell lineages during mouse embryonic development and in adult tissues. Gene Expr Patterns 9, 314-323.
91. Mittaz, L., Russell, D. L., Wilson, T., et al. (2004). Adamts-1 is essential for the development and function of the urogenital system. Biol Reprod 70, 1096-1105.
92. Moake, J. L., Rudy, C. K., Troll, J. H., et al. (1982). Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 307, 1432-1435.
93. Moss, M. L., Jin, S. L. C., Milla, M. E., et al. (1997). Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385, 733-736.
94. Mosyak, L., Georgiadis, K., Shane, T., et al. (2008). Crystal structures of the two major aggrecan degrading enzymes, ADAMTS4 and ADAMTS5. Protein Sci 17, 16-21.
95. Murphy, G., and Nagase, H. (2011). Localizing matrix metalloproteinase activities in the pericellular environment. FEBS J 278, 2-15.
96. Nagase, H., and Kashiwagi, M. (2003). Aggrecanases and cartilage matrix degradation. Arthritis Res Ther 5, 94-103.
97. Nagase, H., Visse, R., and Murphy, G. (2006). Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69, 562-573.
98. Nakamura, M., Sone, S., Takahashi, I., Mizoguchi, I., Echigo, S., and Sasano, Y. (2005). Expression of versican and ADAMTS1, 4, and 5 during bone development in the rat mandible and hind limb. J Histochem Cytochem 53, 1553-1562.
99. Nardi, M., Feinmark, S. J., Hu, L., Li, Z., and Karpatkin, S. (2004). Complement-independent Ab-induced peroxide lysis of platelets requires 12-lipoxygenase and a platelet NADPH oxidase pathway. J Clin Invest 113, 973-980.
100. Nardi, M., Tomlinson, S., Greco, M. A., and Karpatkin, S. (2001). Complement-independent, peroxide-induced antibody lysis of platelets in HIV-1-related immune thrombocytopenia. Cell 106, 551-561.
101. Newby, A. C. (2005). Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 85, 1-31.
102. Nishiwaki, K., Hisamoto, N., and Matsumoto, K. (2000). A metalloprotease disintegrin that controls cell migration in Caenorhabditis elegans. Science 288, 2205-2208.
103. Nusgens, B. V., Verellen-Dumoulin, C., Hermanns-Le, T., et al. (1992). Evidence for a relationship between Ehlers-Danlos type VII C in humans and bovine dermatosparaxis. Nat Genet 1, 214-217.
104. Page-McCaw, A., Ewald, A. J., and Werb, Z. (2007). Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 8, 221-233.
105. Porter, S., Clark, I. M., Kevorkian, L., and Edwards, D. R. (2005). The ADAMTS metalloproteinases. Biochem J 386, 15-27.
106. Richards, J. S. (2005). Ovulation: new factors that prepare the oocyte for fertilization. Mol Cell Endocrinol 234, 75-79.
107. Robker, R. L., Russell, D. L., Espey, L. L., Lydon, J. P., O'Malley, B. W., and Richards, J. S. (2000). Progesterone-regulated genes in the ovulation process: ADAMTS-1 and cathepsin L proteases. Proc Natl Acad Sci U S A 97, 4689-4694.
108. Rodriguez-Manzaneque, J. C., Westling, J., Thai, S. N., et al. (2002). ADAMTS1 cleaves aggrecan at multiple sites and is differentially inhibited by metalloproteinase inhibitors. Biochem Biophys Res Commun 293, 501-508.
109. Ruggeri, Z. M., and Zimmerman, T. S. (1981). The complex multimeric composition of factor VIII/von Willebrand factor. Blood 57, 1140-1143.
110. Russell, D. L., Doyle, K. M., Ochsner, S. A., Sandy, J. D., and Richards, J. S. (2003). Processing and localization of ADAMTS-1 and proteolytic cleavage of versican during cumulus matrix expansion and ovulation. J Biol Chem 278, 42330-42339.
111. Sadler, J. E. (1998). Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem 67, 395-424.
112. Sandy, J. D. (2006). A contentious issue finds some clarity: on the independent and complementary roles of aggrecanase activity and MMP activity in human joint aggrecanolysis. Osteoarthritis Cartilage 14, 95-100.
113. Sandy, J. D., Flannery, C. R., Neame, P. J., and Lohmander, L. S. (1992). The structure of aggrecan fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond of the interglobular domain. J Clin Invest 89, 1512-1516.
114. Sandy, J. D., Neame, P. J., Boynton, R. E., and Flannery, C. R. (1991). Catabolism of aggrecan in cartilage explants. Identification of a major cleavage site within the interglobular domain. J Biol Chem 266, 8683-8685.
115. Shieh, H. S., Mathis, K. J., Williams, J. M., et al. (2008). High resolution crystal structure of the catalytic domain of ADAMTS-5 (aggrecanase-2). J Biol Chem 283, 1501-1507.
116. Shindo, T., Kurihara, H., Kuno, K., et al. (2000). ADAMTS-1: a metalloproteinase-disintegrin essential for normal growth, fertility, and organ morphology and function. J Clin Invest 105, 1345-1352.
117. Silver, D. L., Hou, L., Somerville, R., Young, M. E., Apte, S. S., and Pavan, W. J. (2008). The secreted metalloprotease ADAMTS20 is required for melanoblast survival. PLoS Genet 4, e1000003.
118. Soejima, K., Matsumoto, M., Kokame, K., et al. (2003). ADAMTS-13 cysteine-rich/spacer domains are functionally essential for von Willebrand factor cleavage. Blood 102, 3232-3237.
119. Soejima, K., Mimura, N., Hirashima, M., et al. (2001). A novel human metalloprotease synthesized in the liver and secreted into the blood: possibly, the von Willebrand factor-cleaving protease? J Biochem 130, 475-480.
120. Somerville, R. P., Longpre, J. M., Apel, E. D., et al. (2004). ADAMTS7B, the full-length product of the ADAMTS7 gene, is a chondroitin sulfate proteoglycan containing a mucin domain. J Biol Chem 279, 35159-35175.
121. Somerville, R. P., Longpré, J. M., Jungers, K. A., et al. (2003). Characterization of ADAMTS-9 and ADAMTS-20 as a distinct ADAMTS subfamily related to Caenorhabditis elegans GON-1. J Biol Chem 278, 9503-9513.
122. Stankunas, K., Hang, C. T., Tsun, Z. Y., et al. (2008). Endocardial Brg1 represses ADAMTS1 to maintain the microenvironment for myocardial morphogenesis. Dev Cell 14, 298-311.
123. Stanton, H., Rogerson, F. M., East, C. J., et al. (2005). ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 434, 648-652.
124. Struglics, A., Larsson, S., Pratta, M. A., Kumar, S., Lark, M. W., and Lohmander, L. S. (2006). Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments. Osteoarthritis Cartilage 14, 101-113.
125. Takeda, S. (2009). Three-dimensional domain architecture of the ADAM family proteinases. Semin Cell Dev Biol 20, 146-152.
126. Takeda, S., Igarashi, T., Mori, H., and Araki, S. (2006). Crystal structures of VAP1 reveal ADAMs' MDC domain architecture and its unique C-shaped scaffold. EMBO J 25, 2388-2396.
127. Takeda, S., Takeya, H., and Iwanaga, I. (2012). Snake venom metalloproteinases: structure, function and relevance to the mammalian ADAM/ADAMTS family proteins. Biochim Biophys Acta 1824, 164-176.
128. Tan, K., Duquette, M., Liu, J. H., et al. (2002). Crystal structure of the TSP-1 type 1 repeats: a novel layered fold and its biological implication. J Cell Biol 159, 373-382.
129. Tolsma, S. S., Volpert, O. V., Good, D. J., Frazier, W. A., Polverini, P. J., and Bouck, N. (1993). Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J Cell Biol 122, 497-511.
130. Tortorella, M. D., Burn, T. C., Pratta, M. A., et al. (1999). Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science 284, 1664-1666.
131. Tortorella, M. D., Liu, R. Q., Burn, T., Newton, R. C., and Arner, E. (2002). Characterization of human aggrecanase 2 (ADAM-TS5): substrate specificity studies and comparison with aggrecanase 1 (ADAM-TS4). Matrix Biol 21, 499-511.
132. Troeberg, L., Fushimi, K., Khokha, R., Emonard, H., Ghosh, P., and Nagase, H. (2008). Calcium pentosan polysulfate is a multifaceted exosite inhibitor of aggrecanases. FASEB J 22, 3515-3524.
133. Troeberg, L., Mulloy, B., Ghosh, P., Lee, M. H., Murphy, G., and Nagase, H. (2012). Pentosan polysulfate increases affinity between ADAMTS-5 and TIMP-3 through formation of an electrostatically driven trimolecular complex. Biochem J 443, 307-315.
134. Van Wart, H. E., and Birkedal-Hansen, H. (1990). The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metallo-proteinase gene family. Proc Natl Acad Sci U S A 87, 5578-5582.
135. Vazquez, F., Hastings, G., Ortega, M. A., et al. (1999). METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity. J Biol Chem 274, 23349-23357.
136. Velasco, J., Li, J., DiPietro, L., Stepp, M. A., Sandy, J. D., and Plaas, A. (2011). Adamts5 deletion blocks murine dermal repair through CD44-mediated aggrecan accumulation and modulation of transforming growth factor beta1 (TGFbeta1) signaling. J Biol Chem 286, 26016-26027.
137. Visse, R., and Nagase, H. (2003). Matrix metalloproteinases and tissue inhibitors of metallo-proteinases: structure, function, and biochemistry. Circ Res 92, 827-839.
138. Vogel, T., Guo, N. H., Krutzsch, H. C., et al. (1993). Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin-binding domain and synthetic pep-tides from the type I repeats of thrombospondin. J Cell Biochem 53, 74-84.
139. Wang, L., Zheng, J., Bai, X., et al. (2009). ADAMTS-7 mediates vascular smooth muscle cell migration and neointima formation in balloon-injured rat arteries. Circ Res 104, 688-698.
140. Wang, P., Tortorella, M., England, K., et al. (2004). Proprotein convertase furin interacts with and cleaves pro-ADAMTS4 (Aggrecanase-1) in the trans-Golgi network. J Biol Chem 279, 15434-15440.
141. Wang, W. M., Ge, G., Lim, N. H., Nagase, H., and Greenspan, D. S. (2006). TIMP-3 inhibits the procollagen N-proteinase ADAMTS-2. Biochem J 398, 515-519.
142. Wang, X., Harris, R. E., Bayston, L. J., and Ashe, H. L. (2008). Type IV collagens regulate BMP signalling in Drosophila. Nature 455, 72-77.
143. Woolley, D. E., and Evanson, J. M. (1980). Collagenase in Normal and Pathological Connective Tissue. Chichester: John Wiley.
144. Woolley, D. E., Glanville, R. W., Crossley, M. J., and Evanson, J. M. (1975). Purification of rheumatoid synovial collagenase and its action on soluble and insoluble collagen. Eur J Biochem 54, 611-622.
145. Zeng, W., Corcoran, C., Collins-Racie, L. A., LaVallie, E. R., Morris, E. A., and Flannery, C. R. (2006). Glycosaminoglycan-binding properties and aggrecanase activities of truncated ADAMTSs: comparative analyses with ADAMTS-5, -9, -16 and -18. Biochim Biophys Acta 1760, 517-524.
146. Zhang, D., Botos, I., Gomis-Ruth, F. X., et al. (1994). Structural interaction of natural and synthetic inhibitors with the venom metalloproteinase, atrolysin C (form d). Proc Natl Acad Sci USA 91, 8447-8451.
147. Zhang, Q., Zhou, Y. F., Zhang, C. Z., Zhang, X., Lu, C., and Springer, T. A. (2009a). Structural specializations of A2, a force-sensing domain in the ultralarge vascular protein von Willebrand factor. Proc Natl Acad Sci U S A 106, 9226-9231.
148. Zheng, X., Chung, D., Takayama, T. K., Majerus, E. M., Sadler, J. E., and Fujikawa, K. (2001). Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. J Biol Chem 276, 41059-41063.
149. Zheng, X., Nishio, K., Majerus, E. M., and Sadler, J. E. (2003). Cleavage of von Willebrand factor requires the spacer domain of the metalloprotease ADAMTS13. J Biol Chem 278, 30136-30141.